Search company, investor...

Predict your next investment

Angel Investor (Individual)

Investments

2

About Zeke Emanuel

Zeke Emanuel is an angel investor.

Headquarters Location

Pennsylvania,

United States

Want to inform investors similar to Zeke Emanuel about your company?

Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.

Latest Zeke Emanuel News

Zeke Emanuel Weighs In On $200M Jury Verdict In Favor Of Deceased Patient Denied Proton Beam Therapy Treatment

May 25, 2022

While a jury agreed that an insurance company breeched a good faith contract by not covering proton beam therapy, not all agree that the treatment modality actually improves outcomes for cancer patients. The post Zeke Emanuel Weighs In On $200M Jury Verdict In Favor Of Deceased Patient Denied Proton Beam Therapy Treatment appeared first on Above the Law.

Zeke Emanuel Investments

2 Investments

Zeke Emanuel has made 2 investments. Their latest investment was in Aktivate as part of their Seed VC - II on September 9, 2021.

CBI Logo

Zeke Emanuel Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

9/14/2021

Seed VC - II

Aktivate

$1.87M

No

8

6/3/2021

Seed VC

Subscribe to see more

$99M

Subscribe to see more

10

Date

9/14/2021

6/3/2021

Round

Seed VC - II

Seed VC

Company

Aktivate

Subscribe to see more

Amount

$1.87M

$99M

New?

No

Subscribe to see more

Co-Investors

Sources

8

10

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.